Stock Screener App

Gratuito -

Installare

2.16

2.62% 0.06

Cassava Sciences Inc (SAVA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché SAVA Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Cassava Sciences Inc Borsa (SAVA) Ultime notizie

Cassava Sciences Inc. Stock Analysis and ForecastHigh-yield investments - Jammu Links News

What drives Cassava Sciences Inc. stock pricePowerful market insights - Jammu Links News

Dementia associated with Alzheimer's Disease Clinical Trials, - openPR.com

SAVA STOCK ALERT: Levi & Korsinsky Notifies Cassava Sciences, Inc. Investors of an Ongoing Investigation - ACCESS Newswire

SAVA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Cassava Sciences, Inc. to Contact the Firm Today! - ACCESS Newswire

Cassava Sciences, Inc.(NasdaqCM:SAVA) dropped from Russell Small Cap Comp Growth Index - MarketScreener

Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting - GlobeNewswire

Cassava Sciences reports simufilam reduced seizures in mouse model - Investing.com

Cassava Sciences Reveals Promising Simufilam Preclinical Data - TipRanks

Is Cassava Sciences, Inc. technically bullish or bearish? - MarketsMojo

Shareholders Filed a Lawsuit Against Cassava Sciences for Misleading Alzheimer’s Drug Claims - TradingView

SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Cassava Sciences, Inc. Investors to Lead the Class Action Lawsuit! - ACCESS Newswire

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 10, 2025 in Cassava Sciences, Inc. LawsuitSAVA - ACCESS Newswire

Cassava Sciences, Inc. (NASDAQ:SAVA) Shares Sold by Cetera Investment Advisers - Defense World

BNP Paribas Financial Markets Buys 55,813 Shares of Cassava Sciences, Inc. (NASDAQ:SAVA) - Defense World

Cassava Sciences, Inc. (NASDAQ:SAVA) Stake Lifted by Northern Trust Corp - Defense World

Editas Medicine, Cassava Sciences among healthcare stocks to join Russell Microcap; MNKD, OCGN to exit - Seeking Alpha

Cassava Sciences Holds 2025 Annual Meeting, Elects Directors - TipRanks

Transcript : Cassava Sciences, Inc.Shareholder/Analyst Call - marketscreener.com

Cassava Sciences, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationSAVA - ACCESS Newswire

Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your RightsSAVA - ACCESS Newswire

Class Action Filed Against Cassava Sciences, Inc. (SAVA) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire

Levi & Korsinsky Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025SAVA - ACCESS Newswire

Levi & Korsinsky Notifies Shareholders of Cassava Sciences, Inc.(SAVA) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

Shareholders of Cassava Sciences, Inc. Should Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your RightsSAVA - ACCESS Newswire

Cassava Sciences, Inc. Class Action: Levi & Korsinsky Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025SAVA - ACCESS Newswire

Shareholders that lost money on Cassava Sciences, Inc.(SAVA) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More - ACCESS Newswire

Shareholders that lost money on Cassava Sciences, Inc.(SAVA) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

Class Action Filed Against Cassava Sciences, Inc. (SAVA)February 10, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire

Investors in Cassava Sciences, Inc. Should Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your RightsSAVA - ACCESS Newswire

Cassava Reports Q1 2025 Financials Results, Provides Business Update - GlobeNewswire

Cassava Sciences Shifts Focus to TSC-Related Epilepsy - TipRanks

Cassava Sciences (SAVA) Faces Financial Challenges Amid Strategic Shifts - GuruFocus

Invesco Ltd. Trims Stock Position in Cassava Sciences, Inc. (NASDAQ:SAVA) - Defense World

Press Release Distribution & PR Platform - ACCESS Newswire

Cassava Sciences (SAVA) Appoints New SVP of Neuroscience | SAVA Stock News - GuruFocus

Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC - citybiz

ATTENTION Cassava Sciences, Inc. Investors: You May Have Been Affected by FraudContact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire

GMAB

$22.19

0.86%

RPRX

$35.45

0.37%

INSM

$104.57

0.51%

SMMT

$27.95

1.07%

BNTX

$110.73

0.10%

ONC

$298.88

3.15%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters